# US 2020/0347426 A1 · Multiple Proteases Deficient Filamentous Fungal Cells and Methods of Use Thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0347426 A1
- Document ID: US20200347426A1
- Status: Published application
- Kind: A1
- Application number: 16/933,502
- Filed: 2020-07-20
- Published: 2020-11-05
- Earliest claimed: 2013-07-10
- Assignees: Glykos Finland Oy
- Applicants: Glykos Finland Oy
- Inventors: Christopher Landowski; Anne Huuskonen; Ann Westerholm-Parvinen; Markku Saloheimo; Anne Kanerva; Jukka Hiltunen
- Web page: https://patentgrep.com/patent/US20200347426A1

## CPC

- C12P 21/00: Preparation of peptides or proteins (single cell protein C12N1/00)
- C12N 9/1051: {Hexosyltransferases (2.4.1)}
- C12N 9/14: Hydrolases (3)
- C12N 9/48: acting on peptide bonds (3.4)
- C12N 9/485: {Exopeptidases (3.4.11-3.4.19)}
- C12N 9/58: derived from fungi
- C12N 15/80: for fungi
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- C12Y 204/01258: Dolichyl-P-Man:Man5GlcNAc2-PP-dolichol alpha-1,3-mannosyltransferase (2.4.1.258)
- C12Y 303/02006: Leukotriene-A4 hydrolase (3.3.2.6)
- C12Y 304/00: Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y 304/17021: Glutamate carboxypeptidase II (3.4.17.21)
- C12Y 304/21: Serine endopeptidases (3.4.21)
- C12Y 304/21062: Subtilisin (3.4.21.62)
- C12Y 304/21078: Granzyme A (3.4.21.78)
- C12Y 304/23: Aspartic endopeptidases (3.4.23)
- C12Y 304/23018: Aspergillopepsin I (3.4.23.18)
- C12Y 304/24: Metalloendopeptidases (3.4.24)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

The present disclosure relates to compositions and methods useful for the production of heterologous proteins in filamentous fungal cells.

## Claims

### Claim at position 1

1-16. (canceled)

### Claim 17

A Myceliophthora thermophila filamentous fungal cell comprising at least one endogenous metalloprotease having no protease activity and a recombinant polynucleotide encoding a mammalian polypeptide, wherein a gene encoding an endogenous metalloprotease having at least 50% identity to SEQ ID NO: 875), SEQ ID NO:876, SEQ ID NO:877, SEQ ID NO:878 or SEQ ID NO:879 of the Myceliophthora thermophila filamentous fungal cell comprises a mutation that eliminates the activity of the endogenous metalloprotease.

### Claim 18 (depends on 17)

The Myceliophthora thermophila filamentous fungal cell of claim 17, wherein the gene encoding endogenous metalloprotease is deleted.

### Claim 19 (depends on 17)

The Myceliophthora thermophila cell of claim 17 comprising at least three, four, five, six, seven or eight endogenous proteases having eliminated activity.

### Claim 20 (depends on 19)

The Myceliophthora thermophila cell of claim 19, wherein the proteases are selected from the group consisting of aspartic proteases, trypsin-like serine proteases, subtilisin proteases, glutamic proteases, and metalloproteases.

### Claim 21 (depends on 20)

The Myceliophthora thermophila cell of claim 20, wherein the Myceliophthora thermophila cell has no detectable protease activity of pep4 protease having at least 98% identity to SEQ ID NO: 499, slp2 protease having at least 98% identity to SEQ ID NO: 540, and slp3 protease having at least 98% identity to SEQ ID NO: 546.

### Claim 22 (depends on 17)

The Myceliophthora thermophila cell of claim 17, wherein the mammalian polypeptide is selected from the group consisting of an antibody, a growth factor, an interferon, a cytokine, and an interleukin.

### Claim 23 (depends on 17)

The Myceliophthora thermophila cell of claim 17, wherein the Myceliophthora thermophila cell further comprises ALG3 having eliminated activity.

### Claim 24 (depends on 17)

The Myceliophthora thermophila cell of claim 17, further comprising
a) an N-acetylglucosaminyltransferase I catalytic domain, and,
b) an N-acetylglucosaminyltransferase II catalytic domain.

### Claim 25 (depends on 17)

A method of improving stability of a mammalian polypeptide, comprising
a) providing the Myceliophthora thermophila cell of claim 17, and
b) culturing the Myceliophthora thermophila cell such that the mammalian polypeptide is expressed,
wherein the mammalian polypeptide exhibits increased stability compared to the mammalian polypeptide produced in a corresponding parental Myceliophthora thermophila cell in which the proteases do not have reduced activity.

### Claim 26 (depends on 17)

A method of making a mammalian polypeptide, comprising
a) providing the Myceliophthora thermophila cell of claim 17;
b) culturing the Myceliophthora thermophila cell such that the mammalian polypeptide is expressed; and,
c) purifying the mammalian polypeptide.
